Is Skyrizi approved for treating psoriatic arthritis?
Yes, Skyrizi is approved in adults to treat:
- active psoriatic arthritis
- moderate-to-severe plaque psoriasis in people who are candidates for systemic (body-wide) therapy or skin phototherapy (ultraviolet light therapy)
- moderately to severely active Crohn's disease
- moderately to severely active ulcerative colitis in adults.
Skyrizi, from AbbVie, was approved by the FDA for psoriatic arthritis on January 21, 2022.
Skyrizi studies in psoriatic arthritis
The Skyrizi (risankizumab-rzaa) approval for psoriatic arthritis was supported by two Phase 3, placebo controlled studies, KEEPsAKE-1 and KEEPsAKE-2.
In these studies, adult participants treated with Skyrizi received 4 maintenance doses a year, after first receiving two starter doses. The study included patients who had an inadequate response to non-biologic disease-modifying antirheumatic drugs (DMARDs) and / or biologics.
Results demonstrated improved skin and joint symptoms and physical function at week 24 when compared to a placebo.
- In both studies, significantly more patients treated with Skyrizi achieved the primary endpoint ACR20 (a composite measure that captures at least a 20% improvement in swollen and tender joints, plus other measures) at 24 weeks when compared to the group that received placebo.
- Overall, 57.3% and 51.3% of patients receiving Skyrizi achieved ACR20 (a composite measure that captures at least a 20% improvement in swollen and tender joints, plus other measures) compared to 33.5% and 26.5% of those receiving placebo, respectively.
The sponsor reports that no new safety risks were observed in the psoriatic arthritis studies. Skyrizi can lead to serious side effects such as allergic reactions and increased risk of infections. The most common side effects include upper respiratory infections (13%), headache (3.5%), fatigue (2.5%), injection site reactions (1.5%), and tinea (fungal) infections (1.1%).
Psoriatic arthritis is an inflammatory arthritis associated with plaque psoriasis. Over 30% to 40% of people with plaque psoriasis may develop psoriatic arthritis. Common symptoms are pain, swelling and stiffness, fatigue and loss of ability to fully use the joint.
Other treatments approved by the FDA to treat psoriatic arthritis include:
- Cosentyx (secukinumab)
- Enbrel (etanercept)
- Humira (adalimumab)
- Otezla (apremilast)
- Remicade (infliximab)
- Rinvoq (upadacitinib)
- Selarsdi (ustekinumab-aekn)
- Stelara (ustekinumab)
- Taltz (ixekizumab)
- Tremfya (guselkumab)
- Xeljanz (tofacitinib)
This is not all the information you need to know about Skyrizi for safe and effective use and does not take the place of your healthcare provider's directions. Review the full product information and discuss any questions you have with your doctor or other health care provider.
Related questions
- What does psoriasis look like?
- How do you get psoriasis and is it contagious?
- How does Tremfya work?
References
- Skyrizi FDA Approval History. Drugs.com. Accessed June 20, 2024 at https://www.drugs.com/history/skyrizi.html
- Skyrizi (risankizumab) prescribing information. 6/2024. AbbVie. North Chicago, Illinois. Accessed June 20, 2024 at https://www.rxabbvie.com/pdf/skyrizi_pi.pdf
- AbbVie Submits Regulatory Applications for Skyrizi (risankizumab) in Psoriatic Arthritis to FDA and EMA. Press release. AbbVie. April 7, 2021. Accessed August 12, 2021 at https://news.abbvie.com/news/press-releases/abbvie-submits-regulatory-applications-for-skyrizi-risankizumab-in-psoriatic-arthritis-to-fda-and-ema.htm
Read next
How does Ilumya work to treat psoriasis?
Ilumya works by binding selectively to interleukin-23 (IL-23) which is a naturally occurring cytokine. IL-23 plays a key role in promoting inflammation and regulating other cytokines (such as IL-17) and inflammatory substances, such as TNF-α3-7. By blocking the effects of IL-23, Ilumya helps control the release of IL-17 and TNF-α, which reduces inflammation associated with psoriasis. It also decreases how many inflammatory cells are present within psoriatic lesions, helps prevent plaque formation, and resolves tissue damage. Continue reading
What's a good prednisone taper schedule?
The best prednisone taper will depend upon how long you have been taking the medicine, your dose, and why you are being treated. If you've been treated with a high dose of prednisone, or taken it for more than a few weeks, you will need to slowly stop your medicine, usually over a period of days, weeks or months. Your healthcare provider will determine your prednisone tapering schedule. Continue reading
Prednisone: What are 12 Things You Should Know?
Prednisone first came onto the market over sixty years ago and is still going strong. But did you know that this common drug used for a variety of different conditions also has some pretty serious side effects as well? Continue reading
See also:
Aimovig
Learn about Aimovig (erenumab-aooe) a once-monthly, injectable medication that can be ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Topamax
Topamax (topiramate) is used to prevent seizures in adults and children and to prevent migraine ...
Emgality
Emgality (galcanezumab-gnlm) is a CGRP antagonist for the preventive treatment of migraine and for ...
Timolol
Timolol is used for angina, heart attack, high blood pressure, migraine, migraine prevention
Valproic acid
Valproic acid is used for bipolar disorder, cluster-tic syndrome, epilepsy, headache ...
Divalproex sodium
Divalproex sodium is used for bipolar disorder, borderline personality disorder, cyclothymic ...
Related medical questions
- Where should you not use triamcinolone acetonide cream?
- What are the new drugs for plaque psoriasis?
- Why should I take folic acid with methotrexate?
- Is triamcinolone acetonide an antifungal cream?
- How do you use clobetasol propionate on your scalp?
- Clobetasol vs. triamcinolone - how do they compare?
- What is a substitute for fluocinonide cream?
- Sotyktu vs Otezla: How do they compare?
- How long does methotrexate stay in your system?
- Halobetasol vs. clobetasol - How do they compare?
- Does taking vitamin D help with psoriasis?
- Can clobetasol be used for toenail fungus?
- How long does it take for Skyrizi to work?
- What causes Plaque Psoriasis?
- What are 6 key Taltz side effects to watch out for?
- How does Taltz compare to Cosentyx for psoriatic arthritis?
- How long does clobetasol stay in your system?
- Does Feverfew interact with any drugs?
- What's the dosing schedule for Skyrizi?
- Is fluocinonide an antifungal cream?
- How long does it take for Otezla to work?
- How long should you use fluocinonide for?
- How do you inject Humira?
- Cosentyx vs Humira: How do they compare?
Drug information
Related support groups
- Psoriasis (109 questions, 310 members)
- Skyrizi (17 questions, 9 members)
- Risankizumab (8 questions, 3 members)
- Plaque Psoriasis (94 questions, 69 members)
- Psoriatic Arthritis (91 questions, 282 members)
- Ulcerative Colitis (74 questions, 188 members)
- Crohn's Disease (61 questions, 286 members)